We are live on
!
Find out more
VYNT
Vyant Bio, Inc. Common Stock
VYNT
VYNT
Delisted
VYNT was delisted on the 12th of May, 2023.
23 hedge funds and large institutions have $2.54M invested in Vyant Bio, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
15% less funds holding
Funds holding: 27 → 23 (-4)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
19% less capital invested
Capital invested by funds: $3.12M → $2.54M (-$583K)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
23
Holders Change
-4
Holders Change %
-14.81%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$40.9K |
| 2 |
US Bancorp
Minneapolis,
Minnesota
|
+$27.9K |
| 3 |
State Street
Boston,
Massachusetts
|
+$7.36K |
| 4 |
AWM
AE Wealth Management
Topeka,
Kansas
|
+$3.14K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.65K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Barclays
London,
United Kingdom
| – | +$17 | +3 | New |
|
27
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | +$87 | +15 | +150% |
|